IRCCS Ospedale San Raffaele, Milan
Officially describes hematology, bone marrow transplant and a hospital Stem Cell Program led by Fabio Ciceri.
Italy
This page does not try to name a single "best" doctor or institution. It uses a narrower standard: official pages, documented programs and verifiable roles.
Centers
Officially describes hematology, bone marrow transplant and a hospital Stem Cell Program led by Fabio Ciceri.
Official transplant unit page documents autologous, allogeneic, cord blood and innovative cellular therapies under Nicola Polverelli.
Official company page links its scientific background to Michele De Luca and Graziella Pellegrini in epithelial stem cell-based advanced therapies.
Official pediatric oncohematology page documents care for patients receiving autologous or allogeneic hematopoietic stem cell infusions.
The official diagnostics and laboratory area lists hematology and hematopoietic stem cell transplant directed by Simona Sica.
A formal institutional document references regional clinical pathways for hematopoietic stem cell transplantation in Campania.
By area
Milan and Pavia are prominent for hematology, bone marrow transplant and advanced cell therapy programs.
Rome combines pediatric, university and hospital programs with documented transplant and oncohematology activity.
Naples appears in institutional documentation around regional transplantation pathways.
Professionals
Italian researcher linked to epithelial stem cell science and advanced therapies.
Italian scientist linked to the clinical development of epithelial cell therapies.
Director of the hospital Stem Cell Program at San Raffaele according to the unit page.
Head of the stem cell transplant unit at Policlinico San Matteo according to the official page.
Head of the pediatric oncohematology unit at Bambino Gesu according to the official page.
Contract lecturer in Human Physiology at Universita Europea di Roma; also listed by GVM in orthopedics and spine-related clinical practice. Included here as a documented Italian profile appearing in regenerative medicine outreach, not as a global stem cell biology leader. Within the orthopedic context, the documented profile is senior and publicly recognized, including involvement in the Scaglietti-Dini Prize.